(Q53913324)

22 May 2018

title

Flow cytometry in lymphoma diagnosis and prognosis: useful? (English)

1 reference

22 May 2018

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

27 March 2024

author name string

Maryalice Stetler-Stevenson

1

1 reference

22 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592644

27 March 2024

publication date

1 December 2003

1 reference

22 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S1521692603000689?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

https://api.elsevier.com/content/article/PII:S1521692603000689?httpAccept=text/plain

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

Best Practice and Research: Clinical Haematology

27 March 2024

published in

1 reference

22 May 2018

volume

16

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

583-597

1 reference

22 May 2018

U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Flow cytometric analysis of lymphomas and lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Analysis of lymphomas by flow cytometry. Current and emerging strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Artifactual staining of monoclonal antibodies in two-color combinations is due to an immunoglobulin in the serum and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Diminished CD3 expression is useful for detecting and enumerating Sézary cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Expression of adhesion molecules LFA-1, ICAM-1, CD44, and L-selectin in childhood non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Clinical significance of CD38 expression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Relative importance of CD38 expression over myeloid-associated markers expression in predicting the clinical course of B-CLL patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Flow cytometric detection of total and serine 473 phosphorylated Akt.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Flow-cytometric DNA analysis in the diagnosis and prognosis of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

The bone marrow plasma cell labeling index by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Immunophenotype and DNA cell content in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900068-9

7 January 2021

The cell surface antigen and DNA content distribution of lymph nodes with reactive hyperplasia

8

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

Comparative analysis of immunophenotypic methods for the assessment of minimal residual disease in hairy cell leukemia

27 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

Phenotypic difference of normal plasma cells from mature myeloma cells

27 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma

27 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

Contribution of flow cytometry to the diagnosis of gastric lymphomas in endoscopic biopsy specimens

27 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

Multiparametric flow cytometry in the diagnosis and characterization of low-grade pulmonary mucosa-associated lymphoid tissue lymphomas

27 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

27 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00068-9

27 March 2024

Identifiers

1 reference

22 May 2018

1 reference

22 May 2018